World Journal of Clinical Cases-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2240124, encodeId=15f9224012405, content=本期刊专注于临床医学领域，涵盖临床病例报告和病例研究、疾病诊断与治疗方法、医学临床实践经验、医学研究进展等研究方向。 平均审稿时间为一个月，适合比较快的，但审稿进度有时会停滞的情况。此外，该期刊为开放获取模式，版面费为2250美元。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:49:44 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212188, encodeId=17b822121884f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这本听说on hold了，会不会踢啊，我有一篇刚下录用，到底要不要交版面费啊，求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d2a9339886, createdName=ms1000001292050866, createdTime=Fri Jun 28 22:38:49 CST 2024, time=2024-06-28, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2214248, encodeId=147d221424836, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：6月投的，目前状况是 Wait Peer Review。但是期刊现在on hold了，现在是等评审结果还是主动撤稿呀？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4678805904, createdName=ms8000002047969100, createdTime=Wed Jul 10 13:22:59 CST 2024, time=2024-07-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2223741, encodeId=1e8c2223e41eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：刚接收一篇，就听说被剔除SCI了，是不是真的？重点是小修，需要提供的材料太多了，好不容易弄好了，结果on hold了，在哪里可以查on hold？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ad2044621, createdName=ringyin760, createdTime=Mon Sep 02 20:53:10 CST 2024, time=2024-09-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2215461, encodeId=bf92221546136, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：正在考虑要不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24109389497, createdName=ms4000001210241859, createdTime=Wed Jul 17 17:51:06 CST 2024, time=2024-07-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215460, encodeId=df7322154600f, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：个案 经验分享：World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:50:59 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217392, encodeId=55a0221e3924f, content=审稿速度:3.0 经验分享：已经3个多月了一直在申请审稿人中，这种的该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fd4827727, createdName=1452528939, createdTime=Mon Jul 29 14:43:06 CST 2024, time=2024-07-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2212825, encodeId=2a6e2212825b2, content=一个半月，没有审稿意见，在找审稿人和评审之间反复横跳 - - , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6b58525818, createdName=ms3000000168455776, createdTime=Tue Jul 02 16:25:54 CST 2024, time=2024-07-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211294, encodeId=51a3221129420, content=4月6日投稿，妇科个案，次日至今仍是Reviewed，是谁说很快的？想哭，要拒也要快一点啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da098684506, createdName=ms8000000951566705, createdTime=Sun Jun 23 21:22:09 CST 2024, time=2024-06-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2215459, encodeId=e9f42215459e8, content=World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:49:41 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省)]

2024-11-30 ms2000001788822132 来自上海

本期刊专注于临床医学领域，涵盖临床病例报告和病例研究、疾病诊断与治疗方法、医学临床实践经验、医学研究进展等研究方向。
平均审稿时间为一个月，适合比较快的，但审稿进度有时会停滞的情况。此外，该期刊为开放获取模式，版面费为2250美元。

24 0

[GetPortalCommentsPageByObjectIdResponse(id=2240124, encodeId=15f9224012405, content=本期刊专注于临床医学领域，涵盖临床病例报告和病例研究、疾病诊断与治疗方法、医学临床实践经验、医学研究进展等研究方向。 平均审稿时间为一个月，适合比较快的，但审稿进度有时会停滞的情况。此外，该期刊为开放获取模式，版面费为2250美元。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:49:44 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212188, encodeId=17b822121884f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这本听说on hold了，会不会踢啊，我有一篇刚下录用，到底要不要交版面费啊，求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d2a9339886, createdName=ms1000001292050866, createdTime=Fri Jun 28 22:38:49 CST 2024, time=2024-06-28, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2214248, encodeId=147d221424836, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：6月投的，目前状况是 Wait Peer Review。但是期刊现在on hold了，现在是等评审结果还是主动撤稿呀？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4678805904, createdName=ms8000002047969100, createdTime=Wed Jul 10 13:22:59 CST 2024, time=2024-07-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2223741, encodeId=1e8c2223e41eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：刚接收一篇，就听说被剔除SCI了，是不是真的？重点是小修，需要提供的材料太多了，好不容易弄好了，结果on hold了，在哪里可以查on hold？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ad2044621, createdName=ringyin760, createdTime=Mon Sep 02 20:53:10 CST 2024, time=2024-09-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2215461, encodeId=bf92221546136, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：正在考虑要不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24109389497, createdName=ms4000001210241859, createdTime=Wed Jul 17 17:51:06 CST 2024, time=2024-07-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215460, encodeId=df7322154600f, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：个案 经验分享：World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:50:59 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217392, encodeId=55a0221e3924f, content=审稿速度:3.0 经验分享：已经3个多月了一直在申请审稿人中，这种的该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fd4827727, createdName=1452528939, createdTime=Mon Jul 29 14:43:06 CST 2024, time=2024-07-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2212825, encodeId=2a6e2212825b2, content=一个半月，没有审稿意见，在找审稿人和评审之间反复横跳 - - , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6b58525818, createdName=ms3000000168455776, createdTime=Tue Jul 02 16:25:54 CST 2024, time=2024-07-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211294, encodeId=51a3221129420, content=4月6日投稿，妇科个案，次日至今仍是Reviewed，是谁说很快的？想哭，要拒也要快一点啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da098684506, createdName=ms8000000951566705, createdTime=Sun Jun 23 21:22:09 CST 2024, time=2024-06-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2215459, encodeId=e9f42215459e8, content=World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:49:41 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省)]

2024-06-28 ms1000001292050866 来自广西

审稿速度:3.0 | 投稿命中率:50.0
经验分享：这本听说on hold了，会不会踢啊，我有一篇刚下录用，到底要不要交版面费啊，求助

115 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240124, encodeId=15f9224012405, content=本期刊专注于临床医学领域，涵盖临床病例报告和病例研究、疾病诊断与治疗方法、医学临床实践经验、医学研究进展等研究方向。 平均审稿时间为一个月，适合比较快的，但审稿进度有时会停滞的情况。此外，该期刊为开放获取模式，版面费为2250美元。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:49:44 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212188, encodeId=17b822121884f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这本听说on hold了，会不会踢啊，我有一篇刚下录用，到底要不要交版面费啊，求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d2a9339886, createdName=ms1000001292050866, createdTime=Fri Jun 28 22:38:49 CST 2024, time=2024-06-28, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2214248, encodeId=147d221424836, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：6月投的，目前状况是 Wait Peer Review。但是期刊现在on hold了，现在是等评审结果还是主动撤稿呀？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4678805904, createdName=ms8000002047969100, createdTime=Wed Jul 10 13:22:59 CST 2024, time=2024-07-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2223741, encodeId=1e8c2223e41eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：刚接收一篇，就听说被剔除SCI了，是不是真的？重点是小修，需要提供的材料太多了，好不容易弄好了，结果on hold了，在哪里可以查on hold？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ad2044621, createdName=ringyin760, createdTime=Mon Sep 02 20:53:10 CST 2024, time=2024-09-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2215461, encodeId=bf92221546136, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：正在考虑要不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24109389497, createdName=ms4000001210241859, createdTime=Wed Jul 17 17:51:06 CST 2024, time=2024-07-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215460, encodeId=df7322154600f, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：个案 经验分享：World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:50:59 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217392, encodeId=55a0221e3924f, content=审稿速度:3.0 经验分享：已经3个多月了一直在申请审稿人中，这种的该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fd4827727, createdName=1452528939, createdTime=Mon Jul 29 14:43:06 CST 2024, time=2024-07-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2212825, encodeId=2a6e2212825b2, content=一个半月，没有审稿意见，在找审稿人和评审之间反复横跳 - - , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6b58525818, createdName=ms3000000168455776, createdTime=Tue Jul 02 16:25:54 CST 2024, time=2024-07-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211294, encodeId=51a3221129420, content=4月6日投稿，妇科个案，次日至今仍是Reviewed，是谁说很快的？想哭，要拒也要快一点啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da098684506, createdName=ms8000000951566705, createdTime=Sun Jun 23 21:22:09 CST 2024, time=2024-06-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2215459, encodeId=e9f42215459e8, content=World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:49:41 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省)]

2024-07-10 ms8000002047969100 来自吉林省

审稿速度:3.0 | 投稿命中率:50.0
经验分享：6月投的，目前状况是 Wait Peer Review。但是期刊现在on hold了，现在是等评审结果还是主动撤稿呀？求助

106 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240124, encodeId=15f9224012405, content=本期刊专注于临床医学领域，涵盖临床病例报告和病例研究、疾病诊断与治疗方法、医学临床实践经验、医学研究进展等研究方向。 平均审稿时间为一个月，适合比较快的，但审稿进度有时会停滞的情况。此外，该期刊为开放获取模式，版面费为2250美元。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:49:44 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212188, encodeId=17b822121884f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这本听说on hold了，会不会踢啊，我有一篇刚下录用，到底要不要交版面费啊，求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d2a9339886, createdName=ms1000001292050866, createdTime=Fri Jun 28 22:38:49 CST 2024, time=2024-06-28, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2214248, encodeId=147d221424836, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：6月投的，目前状况是 Wait Peer Review。但是期刊现在on hold了，现在是等评审结果还是主动撤稿呀？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4678805904, createdName=ms8000002047969100, createdTime=Wed Jul 10 13:22:59 CST 2024, time=2024-07-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2223741, encodeId=1e8c2223e41eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：刚接收一篇，就听说被剔除SCI了，是不是真的？重点是小修，需要提供的材料太多了，好不容易弄好了，结果on hold了，在哪里可以查on hold？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ad2044621, createdName=ringyin760, createdTime=Mon Sep 02 20:53:10 CST 2024, time=2024-09-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2215461, encodeId=bf92221546136, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：正在考虑要不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24109389497, createdName=ms4000001210241859, createdTime=Wed Jul 17 17:51:06 CST 2024, time=2024-07-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215460, encodeId=df7322154600f, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：个案 经验分享：World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:50:59 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217392, encodeId=55a0221e3924f, content=审稿速度:3.0 经验分享：已经3个多月了一直在申请审稿人中，这种的该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fd4827727, createdName=1452528939, createdTime=Mon Jul 29 14:43:06 CST 2024, time=2024-07-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2212825, encodeId=2a6e2212825b2, content=一个半月，没有审稿意见，在找审稿人和评审之间反复横跳 - - , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6b58525818, createdName=ms3000000168455776, createdTime=Tue Jul 02 16:25:54 CST 2024, time=2024-07-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211294, encodeId=51a3221129420, content=4月6日投稿，妇科个案，次日至今仍是Reviewed，是谁说很快的？想哭，要拒也要快一点啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da098684506, createdName=ms8000000951566705, createdTime=Sun Jun 23 21:22:09 CST 2024, time=2024-06-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2215459, encodeId=e9f42215459e8, content=World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:49:41 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省)]

2024-09-02 ringyin760 来自广西

审稿速度:3.0 | 投稿命中率:50.0
经验分享：刚接收一篇，就听说被剔除SCI了，是不是真的？重点是小修，需要提供的材料太多了，好不容易弄好了，结果on hold了，在哪里可以查on hold？

74 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240124, encodeId=15f9224012405, content=本期刊专注于临床医学领域，涵盖临床病例报告和病例研究、疾病诊断与治疗方法、医学临床实践经验、医学研究进展等研究方向。 平均审稿时间为一个月，适合比较快的，但审稿进度有时会停滞的情况。此外，该期刊为开放获取模式，版面费为2250美元。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:49:44 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212188, encodeId=17b822121884f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这本听说on hold了，会不会踢啊，我有一篇刚下录用，到底要不要交版面费啊，求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d2a9339886, createdName=ms1000001292050866, createdTime=Fri Jun 28 22:38:49 CST 2024, time=2024-06-28, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2214248, encodeId=147d221424836, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：6月投的，目前状况是 Wait Peer Review。但是期刊现在on hold了，现在是等评审结果还是主动撤稿呀？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4678805904, createdName=ms8000002047969100, createdTime=Wed Jul 10 13:22:59 CST 2024, time=2024-07-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2223741, encodeId=1e8c2223e41eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：刚接收一篇，就听说被剔除SCI了，是不是真的？重点是小修，需要提供的材料太多了，好不容易弄好了，结果on hold了，在哪里可以查on hold？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ad2044621, createdName=ringyin760, createdTime=Mon Sep 02 20:53:10 CST 2024, time=2024-09-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2215461, encodeId=bf92221546136, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：正在考虑要不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24109389497, createdName=ms4000001210241859, createdTime=Wed Jul 17 17:51:06 CST 2024, time=2024-07-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215460, encodeId=df7322154600f, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：个案 经验分享：World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:50:59 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217392, encodeId=55a0221e3924f, content=审稿速度:3.0 经验分享：已经3个多月了一直在申请审稿人中，这种的该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fd4827727, createdName=1452528939, createdTime=Mon Jul 29 14:43:06 CST 2024, time=2024-07-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2212825, encodeId=2a6e2212825b2, content=一个半月，没有审稿意见，在找审稿人和评审之间反复横跳 - - , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6b58525818, createdName=ms3000000168455776, createdTime=Tue Jul 02 16:25:54 CST 2024, time=2024-07-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211294, encodeId=51a3221129420, content=4月6日投稿，妇科个案，次日至今仍是Reviewed，是谁说很快的？想哭，要拒也要快一点啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da098684506, createdName=ms8000000951566705, createdTime=Sun Jun 23 21:22:09 CST 2024, time=2024-06-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2215459, encodeId=e9f42215459e8, content=World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:49:41 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省)]

2024-07-17 ms4000001210241859 来自山东省

审稿速度:3.0 | 投稿命中率:50.0
经验分享：正在考虑要不要投

91 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240124, encodeId=15f9224012405, content=本期刊专注于临床医学领域，涵盖临床病例报告和病例研究、疾病诊断与治疗方法、医学临床实践经验、医学研究进展等研究方向。 平均审稿时间为一个月，适合比较快的，但审稿进度有时会停滞的情况。此外，该期刊为开放获取模式，版面费为2250美元。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:49:44 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212188, encodeId=17b822121884f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这本听说on hold了，会不会踢啊，我有一篇刚下录用，到底要不要交版面费啊，求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d2a9339886, createdName=ms1000001292050866, createdTime=Fri Jun 28 22:38:49 CST 2024, time=2024-06-28, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2214248, encodeId=147d221424836, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：6月投的，目前状况是 Wait Peer Review。但是期刊现在on hold了，现在是等评审结果还是主动撤稿呀？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4678805904, createdName=ms8000002047969100, createdTime=Wed Jul 10 13:22:59 CST 2024, time=2024-07-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2223741, encodeId=1e8c2223e41eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：刚接收一篇，就听说被剔除SCI了，是不是真的？重点是小修，需要提供的材料太多了，好不容易弄好了，结果on hold了，在哪里可以查on hold？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ad2044621, createdName=ringyin760, createdTime=Mon Sep 02 20:53:10 CST 2024, time=2024-09-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2215461, encodeId=bf92221546136, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：正在考虑要不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24109389497, createdName=ms4000001210241859, createdTime=Wed Jul 17 17:51:06 CST 2024, time=2024-07-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215460, encodeId=df7322154600f, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：个案 经验分享：World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:50:59 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217392, encodeId=55a0221e3924f, content=审稿速度:3.0 经验分享：已经3个多月了一直在申请审稿人中，这种的该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fd4827727, createdName=1452528939, createdTime=Mon Jul 29 14:43:06 CST 2024, time=2024-07-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2212825, encodeId=2a6e2212825b2, content=一个半月，没有审稿意见，在找审稿人和评审之间反复横跳 - - , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6b58525818, createdName=ms3000000168455776, createdTime=Tue Jul 02 16:25:54 CST 2024, time=2024-07-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211294, encodeId=51a3221129420, content=4月6日投稿，妇科个案，次日至今仍是Reviewed，是谁说很快的？想哭，要拒也要快一点啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da098684506, createdName=ms8000000951566705, createdTime=Sun Jun 23 21:22:09 CST 2024, time=2024-06-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2215459, encodeId=e9f42215459e8, content=World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:49:41 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省)]

2024-07-17 Hanwin 来自广东省

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：个案
经验分享：World Journal of Clinical Cases已经被剔除SCIE

88 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240124, encodeId=15f9224012405, content=本期刊专注于临床医学领域，涵盖临床病例报告和病例研究、疾病诊断与治疗方法、医学临床实践经验、医学研究进展等研究方向。 平均审稿时间为一个月，适合比较快的，但审稿进度有时会停滞的情况。此外，该期刊为开放获取模式，版面费为2250美元。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:49:44 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212188, encodeId=17b822121884f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这本听说on hold了，会不会踢啊，我有一篇刚下录用，到底要不要交版面费啊，求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d2a9339886, createdName=ms1000001292050866, createdTime=Fri Jun 28 22:38:49 CST 2024, time=2024-06-28, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2214248, encodeId=147d221424836, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：6月投的，目前状况是 Wait Peer Review。但是期刊现在on hold了，现在是等评审结果还是主动撤稿呀？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4678805904, createdName=ms8000002047969100, createdTime=Wed Jul 10 13:22:59 CST 2024, time=2024-07-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2223741, encodeId=1e8c2223e41eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：刚接收一篇，就听说被剔除SCI了，是不是真的？重点是小修，需要提供的材料太多了，好不容易弄好了，结果on hold了，在哪里可以查on hold？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ad2044621, createdName=ringyin760, createdTime=Mon Sep 02 20:53:10 CST 2024, time=2024-09-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2215461, encodeId=bf92221546136, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：正在考虑要不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24109389497, createdName=ms4000001210241859, createdTime=Wed Jul 17 17:51:06 CST 2024, time=2024-07-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215460, encodeId=df7322154600f, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：个案 经验分享：World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:50:59 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217392, encodeId=55a0221e3924f, content=审稿速度:3.0 经验分享：已经3个多月了一直在申请审稿人中，这种的该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fd4827727, createdName=1452528939, createdTime=Mon Jul 29 14:43:06 CST 2024, time=2024-07-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2212825, encodeId=2a6e2212825b2, content=一个半月，没有审稿意见，在找审稿人和评审之间反复横跳 - - , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6b58525818, createdName=ms3000000168455776, createdTime=Tue Jul 02 16:25:54 CST 2024, time=2024-07-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211294, encodeId=51a3221129420, content=4月6日投稿，妇科个案，次日至今仍是Reviewed，是谁说很快的？想哭，要拒也要快一点啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da098684506, createdName=ms8000000951566705, createdTime=Sun Jun 23 21:22:09 CST 2024, time=2024-06-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2215459, encodeId=e9f42215459e8, content=World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:49:41 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省)]

2024-07-29 1452528939 来自山西省

审稿速度:3.0
经验分享：已经3个多月了一直在申请审稿人中，这种的该怎么办

102 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240124, encodeId=15f9224012405, content=本期刊专注于临床医学领域，涵盖临床病例报告和病例研究、疾病诊断与治疗方法、医学临床实践经验、医学研究进展等研究方向。 平均审稿时间为一个月，适合比较快的，但审稿进度有时会停滞的情况。此外，该期刊为开放获取模式，版面费为2250美元。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:49:44 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212188, encodeId=17b822121884f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这本听说on hold了，会不会踢啊，我有一篇刚下录用，到底要不要交版面费啊，求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d2a9339886, createdName=ms1000001292050866, createdTime=Fri Jun 28 22:38:49 CST 2024, time=2024-06-28, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2214248, encodeId=147d221424836, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：6月投的，目前状况是 Wait Peer Review。但是期刊现在on hold了，现在是等评审结果还是主动撤稿呀？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4678805904, createdName=ms8000002047969100, createdTime=Wed Jul 10 13:22:59 CST 2024, time=2024-07-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2223741, encodeId=1e8c2223e41eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：刚接收一篇，就听说被剔除SCI了，是不是真的？重点是小修，需要提供的材料太多了，好不容易弄好了，结果on hold了，在哪里可以查on hold？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ad2044621, createdName=ringyin760, createdTime=Mon Sep 02 20:53:10 CST 2024, time=2024-09-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2215461, encodeId=bf92221546136, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：正在考虑要不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24109389497, createdName=ms4000001210241859, createdTime=Wed Jul 17 17:51:06 CST 2024, time=2024-07-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215460, encodeId=df7322154600f, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：个案 经验分享：World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:50:59 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217392, encodeId=55a0221e3924f, content=审稿速度:3.0 经验分享：已经3个多月了一直在申请审稿人中，这种的该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fd4827727, createdName=1452528939, createdTime=Mon Jul 29 14:43:06 CST 2024, time=2024-07-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2212825, encodeId=2a6e2212825b2, content=一个半月，没有审稿意见，在找审稿人和评审之间反复横跳 - - , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6b58525818, createdName=ms3000000168455776, createdTime=Tue Jul 02 16:25:54 CST 2024, time=2024-07-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211294, encodeId=51a3221129420, content=4月6日投稿，妇科个案，次日至今仍是Reviewed，是谁说很快的？想哭，要拒也要快一点啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da098684506, createdName=ms8000000951566705, createdTime=Sun Jun 23 21:22:09 CST 2024, time=2024-06-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2215459, encodeId=e9f42215459e8, content=World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:49:41 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省)]

2024-07-02 ms3000000168455776 来自四川省

一个半月，没有审稿意见，在找审稿人和评审之间反复横跳 - -

110 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240124, encodeId=15f9224012405, content=本期刊专注于临床医学领域，涵盖临床病例报告和病例研究、疾病诊断与治疗方法、医学临床实践经验、医学研究进展等研究方向。 平均审稿时间为一个月，适合比较快的，但审稿进度有时会停滞的情况。此外，该期刊为开放获取模式，版面费为2250美元。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:49:44 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212188, encodeId=17b822121884f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这本听说on hold了，会不会踢啊，我有一篇刚下录用，到底要不要交版面费啊，求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d2a9339886, createdName=ms1000001292050866, createdTime=Fri Jun 28 22:38:49 CST 2024, time=2024-06-28, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2214248, encodeId=147d221424836, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：6月投的，目前状况是 Wait Peer Review。但是期刊现在on hold了，现在是等评审结果还是主动撤稿呀？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4678805904, createdName=ms8000002047969100, createdTime=Wed Jul 10 13:22:59 CST 2024, time=2024-07-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2223741, encodeId=1e8c2223e41eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：刚接收一篇，就听说被剔除SCI了，是不是真的？重点是小修，需要提供的材料太多了，好不容易弄好了，结果on hold了，在哪里可以查on hold？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ad2044621, createdName=ringyin760, createdTime=Mon Sep 02 20:53:10 CST 2024, time=2024-09-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2215461, encodeId=bf92221546136, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：正在考虑要不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24109389497, createdName=ms4000001210241859, createdTime=Wed Jul 17 17:51:06 CST 2024, time=2024-07-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215460, encodeId=df7322154600f, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：个案 经验分享：World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:50:59 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217392, encodeId=55a0221e3924f, content=审稿速度:3.0 经验分享：已经3个多月了一直在申请审稿人中，这种的该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fd4827727, createdName=1452528939, createdTime=Mon Jul 29 14:43:06 CST 2024, time=2024-07-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2212825, encodeId=2a6e2212825b2, content=一个半月，没有审稿意见，在找审稿人和评审之间反复横跳 - - , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6b58525818, createdName=ms3000000168455776, createdTime=Tue Jul 02 16:25:54 CST 2024, time=2024-07-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211294, encodeId=51a3221129420, content=4月6日投稿，妇科个案，次日至今仍是Reviewed，是谁说很快的？想哭，要拒也要快一点啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da098684506, createdName=ms8000000951566705, createdTime=Sun Jun 23 21:22:09 CST 2024, time=2024-06-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2215459, encodeId=e9f42215459e8, content=World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:49:41 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省)]

2024-06-23 ms8000000951566705 来自湖北省

4月6日投稿，妇科个案，次日至今仍是Reviewed，是谁说很快的？想哭，要拒也要快一点啊......

109 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240124, encodeId=15f9224012405, content=本期刊专注于临床医学领域，涵盖临床病例报告和病例研究、疾病诊断与治疗方法、医学临床实践经验、医学研究进展等研究方向。 平均审稿时间为一个月，适合比较快的，但审稿进度有时会停滞的情况。此外，该期刊为开放获取模式，版面费为2250美元。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:49:44 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212188, encodeId=17b822121884f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这本听说on hold了，会不会踢啊，我有一篇刚下录用，到底要不要交版面费啊，求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d2a9339886, createdName=ms1000001292050866, createdTime=Fri Jun 28 22:38:49 CST 2024, time=2024-06-28, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2214248, encodeId=147d221424836, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：6月投的，目前状况是 Wait Peer Review。但是期刊现在on hold了，现在是等评审结果还是主动撤稿呀？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4678805904, createdName=ms8000002047969100, createdTime=Wed Jul 10 13:22:59 CST 2024, time=2024-07-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2223741, encodeId=1e8c2223e41eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：刚接收一篇，就听说被剔除SCI了，是不是真的？重点是小修，需要提供的材料太多了，好不容易弄好了，结果on hold了，在哪里可以查on hold？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ad2044621, createdName=ringyin760, createdTime=Mon Sep 02 20:53:10 CST 2024, time=2024-09-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2215461, encodeId=bf92221546136, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：正在考虑要不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24109389497, createdName=ms4000001210241859, createdTime=Wed Jul 17 17:51:06 CST 2024, time=2024-07-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215460, encodeId=df7322154600f, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：个案 经验分享：World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:50:59 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217392, encodeId=55a0221e3924f, content=审稿速度:3.0 经验分享：已经3个多月了一直在申请审稿人中，这种的该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fd4827727, createdName=1452528939, createdTime=Mon Jul 29 14:43:06 CST 2024, time=2024-07-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2212825, encodeId=2a6e2212825b2, content=一个半月，没有审稿意见，在找审稿人和评审之间反复横跳 - - , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6b58525818, createdName=ms3000000168455776, createdTime=Tue Jul 02 16:25:54 CST 2024, time=2024-07-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211294, encodeId=51a3221129420, content=4月6日投稿，妇科个案，次日至今仍是Reviewed，是谁说很快的？想哭，要拒也要快一点啊......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da098684506, createdName=ms8000000951566705, createdTime=Sun Jun 23 21:22:09 CST 2024, time=2024-06-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2215459, encodeId=e9f42215459e8, content=World Journal of Clinical Cases已经被剔除SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Wed Jul 17 17:49:41 CST 2024, time=2024-07-17, status=1, ipAttribution=广东省)]

2024-07-17 Hanwin 来自广东省

World Journal of Clinical Cases已经被剔除SCIE

91 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务